Urology · Powell, TN
NPI
1699775718
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7557 Dannaher Dr Ste 230
Powell, TN, 37849
Phone (865) 938-5222
Groups this clinician bills Medicare through
Medicare paid, 2024
$401K
18,080 services
Medicare patients, 2024
956
Average age 75
Drug cost, 2024
$1.8M
4,525 prescriptions
Company payments, 2025
$650
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lee Congleton III was code J1071 (injection, testosterone cypionate, 1 mg), 7,250 times for 13 patients. In total Lee Congleton III billed 18,080 services in 82 codes, and Medicare paid $401K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 7,250 | 13 | $0.01 | $106 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,062 | 151 | $44.14 | $47K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 963 | 131 | $43.78 | $42K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 906 | 686 | $11.49 | $10K |
| 81003 Clinical Chemistry | Office | 776 | 635 | $2.18 | $1,695 |
| 99214 Office E&M - Established | Office | 647 | 498 | $85.52 | $55K |
| 51798 Ultrasound - Nonspecific | Office | 473 | 399 | $7.34 | $3,474 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 353 | 110 | $34.66 | $12K |
| 36415 Venipuncture Blood Collection | Office | 287 | 244 | $8.57 | $2,459 |
| 99204 Office E&M - New | Office | 235 | 235 | $104.62 | $25K |
| 52000 Cystourethroscopy | Facility | 211 | 195 | $56.24 | $12K |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 139 | 60 | $34.46 | $4,790 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 122 | 109 | $40.91 | $4,991 |
| 52442 Cystourethroscopy | Facility | 108 | 28 | $36.46 | $3,938 |
| 99214 Office E&M - Established | Facility | 68 | 65 | $71.97 | $4,894 |
By year: 2022 $296K for 41,666 services; 2023 $386K for 25,860 services; 2024 $401K for 18,080 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 776 | 635 | $2.18 | $1,695 |
| 36415 Venipuncture Blood Collection | 287 | 244 | $8.57 | $2,459 |
Medicare prescription drug claims, 2024
In 2024, the drug Lee Congleton III prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 1,347 prescriptions and refills. In total Lee Congleton III wrote 4,525 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 1,347 | 3,866 | 543 | $32K |
| Tamsulosin Hcl Generic | 695 | 1,950 | 258 | $12K |
| Finasteride Generic | 486 | 1,371 | 165 | $6,023 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 302 | 855 | 117 | $7,095 |
| Solifenacin Succinate Generic | 226 | 580 | 118 | $14K |
| Ciprofloxacin Hcl Generic | 192 | 192 | 169 | $886 |
| Gemtesa Vibegron | 168 | 278 | 42 | $130K |
| Trimethoprim Generic | 106 | 256 | 49 | $8,412 |
| Myrbetriq Mirabegron | 95 | 178 | 41 | $77K |
| Doxycycline Hyclate Generic | 75 | 87 | 66 | $1,288 |
| Orgovyx Relugolix | 74 | 78 | 17 | $207K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 72 | 150 | 36 | $2,957 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 58 | 58 | 53 | $306 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 46 | 64 | 41 | $1,299 |
| Testosterone Cypionate Generic | 45 | 101 | 20 | $2,163 |
Brand drugs: - claims; generic drugs: 3,976 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lee Congleton III $650 ($650 in general payments such as food, travel and fees) from 9 companies. The largest payer was C. R. Bard, Inc. & Subsidiaries with $220.
| Company | Payments | Amount |
|---|---|---|
| C. R. Bard, Inc. & Subsidiaries BDX | 14 | $220 |
| Boston Scientific Corporation BSX | 14 | $170 |
| Abbvie Inc. ABBV | 4 | $103 |
| Valencia Technologies Corporation | 2 | $56.64 |
| Progenics Pharmaceuticals, Inc. | 1 | $22.64 |
| Janssen Biotech, Inc. JNJ | 1 | $22.44 |
| Ferring Pharmaceuticals Inc. | 1 | $19.81 |
| Laborie Medical Technologies Corp. | 2 | $17.78 |
| Teleflex LLC TFX | 1 | $16.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.